ALIGN TECHNOLOGY INC

Align Technology, Inc. (NASDAQ: ALGN) operates as a global medical device company headquartered in Tempe, Arizona, with regional operations across the Americas, Europe, Middle East, Africa, and Asia Pacific. The company's website is www.aligntech.com.

Align designs, manufactures, and markets the Invisalign system of clear aligners for treating malocclusion, or misalignment of teeth, alongside complementary products and services including Vivera retainers, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing software. The company operates through two reportable segments: Clear Aligner, which represents approximately 80 percent of worldwide net revenues, and Imaging Systems and CAD/CAM Services, which accounts for the remaining 20 percent.

The Invisalign System represents the company's flagship offering, comprising custom-manufactured clear polymer aligners based on proprietary computer-simulated treatment plans. The system received FDA 510(k) clearance in 1998 and has treated over 22 million patients worldwide. Align offers multiple treatment packages ranging from Invisalign Express for mild cases to Invisalign Comprehensive for complex malocclusions, along with specialized products including Invisalign First for younger patients and the Invisalign Palatal Expander System for skeletal expansion.

The Align Digital Platform serves as the foundation of the company's strategy, integrating software, systems, and services to create seamless workflows across diagnosis, treatment planning, execution, and monitoring stages. The platform encompasses tools such as ClinCheck treatment planning software, iTero intraoral scanners with advanced imaging capabilities including near-infrared technology for caries detection, and exocad software for restorative dentistry applications.

Align sells primarily through a dedicated sales force to orthodontists, general dental practitioners, dental support organizations, and dental laboratories across more than 100 countries. The company maintains 11 fabrication and treatment planning locations globally, with manufacturing facilities in Mexico, China, and Poland. In January 2024, Align completed the acquisition of Cubicure GmbH to enhance direct 3D printing capabilities for manufacturing custom devices. The company's intellectual property portfolio includes numerous trademarks such as Invisalign, iTero, exocad, ClinCheck, and Vivera, among others.